DoW Rare Cancers Idea Development Award
Summary: The fiscal year 2026 (FY26) Rare Cancers Research Program (RCRP) Idea Development Award (IDA) promotes ideas that are ready for further development and have the potential to yield high-impact findings and new avenues of investigation. Offered by Defense Health Agency Contracting Activity - DHACA; awards $7.3M; applications due November 18, 2026.
Key Facts
- Funder
- Defense Health Agency Contracting Activity - DHACA
- Award amount
- $7.3M
- Deadline
- November 18, 2026
- Geography
- United States
- Categories
- Research
- Status
- Open
About This Grant
Summary: The fiscal year 2026 (FY26) Rare Cancers Research Program (RCRP) Idea Development Award (IDA) promotes ideas that are ready for further development and have the potential to yield high-impact findings and new avenues of investigation. Distinctive Features: The RCRP encourages applicants to include an exploratory aim or sub-aim to support any necessary discovery-driven research. Preliminary data with disease-specific rationale are required. However, these data do not necessarily need to...
Full requirements and application instructions: official listing.
Similar Open Grants
DoW Neurofibromatosis Investigator-Initiated Research Award
Defense Health Agency Contracting Activity - DHACA
DoW Neurofibromatosis Research Academy – Scholar Award
Defense Health Agency Contracting Activity - DHACA
DoW Neurofibromatosis Exploration-Hypothesis Development Award
Defense Health Agency Contracting Activity - DHACA
DoW Neurofibromatosis Synergistic Idea Award
Defense Health Agency Contracting Activity - DHACA
DoW Duchenne Muscular Dystrophy, Clinical/Translational Research Award
Defense Health Agency Contracting Activity - DHACA
DOW Combat Readiness – Medical Research Program Translational Research Award
Defense Health Agency Contracting Activity - DHACA
DoW Rare Cancers Resource and Community Development Award
Defense Health Agency Contracting Activity - DHACA
Ethical, Legal and Social Implications (ELSI) Exploratory/Developmental Research Grant (R21 Clinical Trial Optional)
National Institutes of Health
Ethical, Legal and Social Implications (ELSI) Research (R01 Clinical Trial Optional)
National Institutes of Health